Sunday, September 4, 2011

The price of prolonging life

In the Los Angeles Times, the aptly named David Lazarus writes about “Putting a price on prolonging a doomed life.” Writes Lazarus: “Clearly there are limits to how much can and should be done to prolong the lives of the terminally ill. But this is a matter for medical experts, not insurance bean counters, to address. A doctor is in the best position to determine what's most appropriate for his or her patient.”


To which Thaddeus Pope responds, on his Medical Futility blog: “On this I had rather thought that the overwhelming consensus was just the opposite. Physician practice patterns are quite strongly guided by the reimbursement incentives. So, too often, if it's paid for it will be bought -- whether it is wanted by the patient, whether it is beneficial for the patient.”


See the full LA Times column at http://lat.ms/pDzTSn


2 comments:

  1. Physician practice patterns are quite strongly guided by the reimbursement incentives. So, too often, if it's paid for it will be bought -- whether it is wanted by the patient, whether it is beneficial for the patient.” http://findmybud.com/

    ReplyDelete
  2. Caverta is a male enhancement drug created to assist men who may be dealing with erectile dysfunction or other negative sexual issues.caverta online

    ReplyDelete